Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Henk Boot

1PUBLICATIONS

13CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (1)

Sort by Publication Date:

|Jul 15, 2017

Treatment of Peritoneal Dissemination in Stomach Cancer Patients With Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Rationale and Design of the PERISCOPE Study.

Rosa T van der Kaaij, Hidde Jw Braam, Henk Boot

Pageof 1

Frequent Collaborators

1 joint publications

Rosa T van der Kaaij

1 joint publications

Hidde Jw Braam

1 joint publications

Maartje Los

1 joint publications

Annemieke Cats

1 joint publications

Cecile Grootscholten

1 joint publications

Jan Hm Schellens

1 joint publications

Arend Gj Aalbers

1 joint publications

Alwin Dr Huitema

1 joint publications

Catherijne Aj Knibbe

1 joint publications

Djamila Boerma

Frequent Collaborators

1 joint publications

Rosa T van der Kaaij

1 joint publications

Hidde Jw Braam

1 joint publications

Maartje Los

1 joint publications

Annemieke Cats

Top Related Videos

Percutaneous Hepatic Perfusion (PHP) with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver

Percutaneous Hepatic Perfusion (PHP) with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver

Published on : Jul 31, 2016

See more related videos

Top Related Videos

Percutaneous Hepatic Perfusion (PHP) with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver

Percutaneous Hepatic Perfusion (PHP) with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver

Published on : Jul 31, 2016

See more related videos